Open access journals: Why are we not there yet? (!)
Gregory J. Gores – 24 September 2010
Gregory J. Gores – 24 September 2010
Kuok Teong Ong, Mara T. Mashek, So Young Bu, Andrew S. Greenberg, Douglas G. Mashek – 24 September 2010 – Despite advances in our understanding of the ways in which nutrient oversupply and triacylglycerol (TAG) anabolism contribute to hepatic steatosis, little is known about the lipases responsible for regulating hepatic TAG turnover. Recent studies have identified adipose triglyceride lipase (ATGL) as a major lipase in adipose tissue, although its role in the liver is largely unknown. Thus, we tested the contribution of ATGL to hepatic lipid metabolism and signaling.
Liang Xi, Changting Xiao, Robert H.J. Bandsma, Mark Naples, Khosrow Adeli, Gary F. Lewis – 24 September 2010 – Plasma C‐reactive protein (CRP) concentration is increased in the metabolic syndrome, which consists of a cluster of cardiovascular disease risk factors, including insulin resistance. It is not known, however, whether CRP is merely a marker of accompanying inflammation or whether it contributes causally to insulin resistance. The objective of this study is to investigate the role that CRP may play in the development of insulin resistance.
Kathrin Schmich, Rebekka Schlatter, Nadia Corazza, Karine Sá Ferreira, Michael Ederer, Thomas Brunner, Christoph Borner, Irmgard Merfort – 24 September 2010 – Fas/CD95 is a critical mediator of cell death in many chronic and acute liver diseases and induces apoptosis in primary hepatocytes in vitro. In contrast, the proinflammatory cytokine tumor necrosis factor α (TNFα) fails to provoke cell death in isolated hepatocytes but has been implicated in hepatocyte apoptosis during liver diseases associated with chronic inflammation.
Kenya Yamanaka, Etsuro Hatano, Masato Narita, Koji Kitamura, Atsuko Yanagida, Hiroyuki Asechi, Hiromitsu Nagata, Kojiro Taura, Takashi Nitta, Shinji Uemoto – 21 September 2010 – After extended hepatectomy, excessive shear stress in the remnant liver causes postoperative liver failure. Olprinone (OLP), a selective phosphodiesterase inhibitor, has been reported to improve microcirculation and attenuate inflammation. The aim of this study was to investigate the effects of OLP on shear stress in rats with an excessive hepatectomy (EHx) model.
John F. Renz – 21 September 2010
Kenneth Siu Ho Chok, See Ching Chan, Tan To Cheung, William Wei Sharr, Albert Chi Yan Chan, Chung Mau Lo, Sheung Tat Fan – 21 September 2010 – Duct‐to‐duct anastomosis (DDA) and hepaticojejunostomy (HJ) are options for biliary reconstruction in patients undergoing adult‐to‐adult right lobe living donor liver transplantation (ARLDLT), after which biliary anastomotic stricture (BAS) is common as a complication. The risk factors for BAS are not clearly defined. We aimed to determine the rate of post‐ARLDLT BAS in our center and its associated factors.
Dennis Eurich, Marcus Bahra, Sabine Boas‐Knoop, Johan F. Lock, Jennifer Golembus, Ruth Neuhaus, Peter Neuhaus, Ulf P. Neumann – 21 September 2010 – Re‐infection with the hepatitis C virus (HCV) is an important development after liver transplantation (LT); it can lead to graft fibrosis. The aim of this study was to assess the role of transforming growth factor β1 (TGF‐β1) polymorphisms in the development of HCV‐related graft disease by evaluating protocol liver biopsies.
Boris Blechacz, Gregory J. Gores – 20 September 2010
Herbert Tilg, Alexander R. Moschen – 20 September 2010 – Whereas in most cases a fatty liver remains free of inflammation, 10%‐20% of patients who have fatty liver develop inflammation and fibrosis (nonalcoholic steatohepatitis [NASH]). Inflammation may precede steatosis in certain instances. Therefore, NASH could reflect a disease where inflammation is followed by steatosis. In contrast, NASH subsequent to simple steatosis may be the consequence of a failure of antilipotoxic protection.